Bluestem Biosciences

[ita]

Nebraska startup announces $5 million pre-seed funding round

Bluestem Biosciences, a renewable chemicals company maximizing agriculture and energy infrastructure through synthetic biology, announced today a pre-seed financing round of $5 million. Zero Infinity Partners led the round, including participation from Matt Vining, CEO of Navigator CO2 Ventures; Invest Nebraska; angel investor Robert Sali and Bluestem Co-Founder & CEO Billy Hagstrom.

Founded in January 2022, Bluestem focuses on the sustainable bio-production of chemicals through anaerobic fermentation. The company aims to produce these chemicals on an industrial scale. Their mission to diversify and decarbonize the chemical industry begins with purpose-built biology for existing infrastructure, according to today’s press release.

“Bluestem’s approach on decarbonizing the petrochemical industry represents a large opportunity for Bluestem and our strategic partners,” said Billy Hagstrom. “Through our recent patent application and accomplishments year-to-date, Bluestem and our growing team are well-positioned to transform infrastructure, beginning in the Midwest.”

The pre-seed funding will be used to build a leading team and product discovery pipeline powered by Bluestem’s proprietary digital biology architecture. This internally developed technology will allow Bluestem to accelerate discovery through an integration of existing and custom tools, focused on anaerobic bioproduction.